ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Diagnostic Deals: Urgent Need for Coronavirus Diagnostics Fuels Strategic Collaboration
...
Already a member? Log in here
The DX Pipeline: OraSure Subsidiary’s DNA Test Sample Collection Kit Gets FDA Greenlight
...
Already a member? Log in here
FDA Watch: Agency to Use EUA Pathway to Clear New Coronavirus Detection Tests
...
Already a member? Log in here
Strategic planning needs to evolve over time
...
Already a member? Log in here
Diagnostic Deals: Lab Corp & Quest to Continue Targeting Small and Independent Labs for Acquisition
PAMA price cuts were supposed to drive consolidation in the lab market. The expectation was that price pressures would make it impossible for smaller labs to remain independent, rendering them juicy targets for the likes of
Agency to Use EUA Pathway to Clear New Coronavirus Detection Tests
...
Already a member? Log in here
Lab Companies Scramble to Bring Coronavirus Detection Tests to Market
...
Already a member? Log in here
Doing What We’ve Always Done
...
Already a member? Log in here
Finding the “Backdoor” into Payer Networks
...
Already a member? Log in here
New overtime rule now in effect
...
Already a member? Log in here